London · Delayed Price · Currency is GBP · Price in GBX Inspiration Healthcare Group Earnings Call Transcripts
Fiscal Year 2026
-
Record revenue growth of 24% was driven by large one-off orders and 10% underlying business growth, with significant efficiency gains and inventory reduction. SLE segment led performance, while new consumables and service launches are set to boost recurring revenues. Long-term EBITDA margin target is 15%.
-
Record H1 revenue and return to profitability driven by major export contracts and underlying growth. Gross margin and cash flow improved, with reduced net debt and strong outlook for H2. Strategic focus on U.S. market entry, operational efficiency, and brand realignment.
Fiscal Year 2025
-
FY25 saw organizational restructuring, cost savings, and a strong H2 turnaround, with infusion therapy and Aeron segments outperforming. Gross margin declined, but large new contracts and a focus on recurring revenue and operational efficiency support a positive FY26 outlook.